INSIGHTS ON QUALITY CONTROL

  • Isokinetic Sampling In Unidirectional Flow
    3/5/2026

    Accurate cleanroom particle monitoring requires precise isokinetic sampling. Understand how to maintain sampling accuracy and meet regulatory airflow requirements for your facility.

  • Esco IntelliGlove Tester (EIGT)
    2/19/2026

    Ensure sterility with wireless glove leak testing. Align with Annex 1 and ISO standards through portable, traceable, and cable-free integrity checks that optimize cleanroom safety and workflows.

  • Aggregate Analysis Of Semaglutide
    12/11/2025

    Effective size exclusion chromatography (SEC) for Semaglutide aggregate analysis is possible without high organic solvents or acidic modifiers. Learn about this robust method for improved efficacy.

  • Glucagon-Like Peptide-1 (GLP-1) Analogues Applications Notebook
    12/11/2025

    View this collection of application notes about the chromatographic analysis and purification of GLP-1 analogues, including Semaglutide, Tirzepatide, Liraglutide, and Exenatide.

  • Quantifying Endotoxins Via Absorbance Or Fluorescence
    3/20/2026

    Find out how endotoxin assays use Factor C activation to generate measurable absorbance or fluorescence signals, with guidance on selecting detection formats and implementing scalable workflows.

QUALITY CONTROL SOLUTIONS

  • Explore an extensive analytical chemistry and microbial testing compliant portfolio for pharmaceutical analysis and quality control (QC) from early-stage drug development to product release.

  • Mikart’s small-scale non-GMP lab accelerates development by enabling rapid testing and iteration at a lower cost.

  • The pharmaceutical industry continues to bring breakthroughs in the field of new vaccines and drug delivery systems amidst the increased scrutiny of the regulators. The packaging acts as the primary sterile barrier in drug delivery systems that safeguard the drug product through its life cycle. The efficiency of the primary sterile barrier and the functional components are of utmost importance to patient safety.

  • Wearable technologies that allow for dosing of high-volume biologics over a longer time need to be designed with manufacturability end-user needs in mind and must comply with the highest quality and regulatory standards.

  • Ensure Compliance. Safeguard Sterility. Drive Manufacturing Excellence.